USPTO serial 79453321
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management; medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; business consulting services in the field of medical coding in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; business assistance, management and administrative services in the field of reimbursement services, namely, reimbursement strategies and support to companies involved in the healthcare field; market assessment services; management of telephone call centers for others; customer relationship management; outsourcing services in the field of customer relationship management. | ACTIVE | — |
| 042 | Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, including orthopedic, cardiovascular, dermatology, and aesthetics; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to health authorities by tech- and life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; scientific laboratory services; research and development of new products for others; industrial analysis and research services for medical technology; design and development of medical technology; design of prototypes; materials testing and analysing; software design and development for medical devices and equipment; quality evaluation of medical devices and equipment. | ACTIVE | — |
| 045 | Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to assure compliance with laws and regulations concerning protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the field of biotechnology, cybersecurity, medical technology, pharmaceuticals, healthcare, and life sciences; legal advocacy, information and support services; legal consultation services in the field of good manufacturing practice (GMP), good clinical practice (GCP), and good laboratory practice (GLP) documentation and compliance with regulatory and policy standards for these industries. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 9, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |